Intravenous D‑allose administration improves blood glucose control by maintaining insulin secretion in diabetic mice with transplanted islets
Authors:
Open Access
- 30 January 2025
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 29 (4) , 1-11
Abstract
Although pancreatic islet transplantation outcomes have improved, further refinements are required to extend the insulin withdrawal period. The present study examined whether intravenous D‑allose administration improves insulin secretion when pancreatic islets are transplanted into type 1 diabetes model mice. Alterations in casual blood glucose levels, intraperitoneal glucose tolerance test (IPGGT) results, the number of apoptotic cells in the engrafted cells, and caspase 3, heme oxygenase 1 and nitric oxide synthase 2 (NOS2) expression in the engrafted cells were examined using the following groups of type 1 diabetic model mice with transplanted pancreatic islets: Mice that received an intravenous injection of D‑allose (D‑group) and those that received physiological saline as a control (C‑group). The mice in the D‑group had significantly lower casual blood sugar levels for a longer duration than those in the C‑group. Regarding IPGGT, mice treated with D‑allose exhibited smaller changes in blood glucose levels compared with untreated mice. Consequently, the incremental area under the curve of glucose in D‑allose‑treated mice was significantly lower than that in D‑allose‑untreated mice. No difference was observed in the number of engrafted cells between the groups. NOS2 mRNA expression in the engrafted cells of the D‑group tended to be higher than that in the C‑group. In conclusion, intravenous administration of D‑allose significantly improved hyperglycemia and maintained stable blood glucose levels in type 1 diabetic mice after islet transplantation. Since there was no difference in the number of engrafted cells or apoptotic cells with or without intravenous D‑allose administration, D‑allose was considered to be effective in maintaining the cellular function of insulin secretion.Keywords
This publication has 40 references indexed in Scilit:
- D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injuryBrain Research, 2016
- Beneficial effect of D‐allose for isolated islet culture prior to islet transplantationJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- Protective role of hemeoxygenase-1 in gastrointestinal diseasesCellular and Molecular Life Sciences, 2014
- β-Cell Responses to Nitric Oxide2014
- The rare sugar D-allose has a reducing effect against ischemia-reperfusion injury on the rat abdominal skin island flap modelJournal of Surgical Research, 2013
- Metabolomics analysis of umbilical cord blood clarifies changes in saccharides associated with delivery methodEarly Human Development, 2013
- Anti-oxidative effects of d-allose, a rare sugar, on ischemia-reperfusion damage following focal cerebral ischemia in ratNeuroscience Letters, 2011
- Izumoring: A strategy for bioproduction of all hexosesJournal of Biotechnology, 2006
- Protective effects of d-allose against ischemia reperfusion injury of the rat liverJournal of Hepato-Biliary-Pancreatic Surgery, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001